Provided by Tiger Fintech (Singapore) Pte. Ltd.

West Pharmaceutical

203.21
-16.7600-7.62%
Post-market: 203.210.00000.00%19:44 EDT
Volume:988.37K
Turnover:204.29M
Market Cap:14.69B
PE:30.38
High:218.53
Open:218.53
Low:202.86
Close:219.97
Loading ...
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 13, 2024

Major Issues Report

Form 8-K - Current report
Dec 11, 2024

Major Issues Report

Form 8-K - Current report
Oct 24, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 24, 2024

Major Issues Report

Form 8-K - Current report
Oct 23, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 23, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 08, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 25, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 25, 2024

Major Issues Report

Form 8-K - Current report
Jul 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 26, 2024

Employee Stock Ownership

Form 11-K - Annual report of employee stock purchase, savings and similar plans
Jun 26, 2024

Employee Stock Ownership

Form 11-K - Annual report of employee stock purchase, savings and similar plans
May 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 26, 2024

Major Issues Report

Form 8-K - Current report
Apr 25, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]